Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propranolol ER for Pain in Temporomandibular Disorder (SOPPRANO)
NCT02437383Phase 2Completed
- Sponsor
- University of North Carolina at Chapel Hill
- Start
- Aug 2015
- Primary completion
- Apr 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of propranolol in temporomandibular disorder (TMD), sponsored by University of North Carolina at Chapel Hill. Started Aug 2015; status: completed.
02
Drugs
propranolol
03
Conditions
temporomandibular disorder (TMD)
Beyond the preview
Go deeper on NCT02437383.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02437383.